← FDA DRUG APPROVALS

FDA ANDA · ANDA076061

PERGOLIDE MESYLATE

Sponsor: STRIDES PHARMA

APPLICATION
ANDA076061
TYPE
ANDA
ORIGINAL APPROVAL
2002-11-27
LATEST ACTION
2004-03-08
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

PERGOLIDE MESYLATEDiscontinued
PERGOLIDE MESYLATE EQ 1MG BASE · TABLET · ORAL
PERGOLIDE MESYLATEDiscontinued
PERGOLIDE MESYLATE EQ 0.05MG BASE · TABLET · ORAL
PERGOLIDE MESYLATEDiscontinued
PERGOLIDE MESYLATE EQ 0.25MG BASE · TABLET · ORAL

Approval history

2004-03-08Labeling · Supplement 2AP
2002-11-27Original — Other Important Information from FDA ↗AP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →